{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:11:32Z","timestamp":1790662292176,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.jim.2004.01.016","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T11:41:51Z","timestamp":1078573311000},"page":"49-65","source":"Crossref","is-referenced-by-count":28,"title":["Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay"],"prefix":"10.1016","volume":"287","author":[{"given":"David","family":"Opalka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Pessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Ciliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schleif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McElhaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Danzeisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romas","family":"Geleziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra M.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bramhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Magilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2004.01.016_BIB1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/72309","article-title":"Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection","volume":"6","author":"Baba","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2004.01.016_BIB2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-2836(03)00611-9","article-title":"Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion","volume":"330","author":"Barbato","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jim.2004.01.016_BIB3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.2986291","article-title":"Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients","volume":"228","author":"Barin","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.jim.2004.01.016_BIB4","series-title":"Peptides 2002. Proc. 27th Eur. Peptide Symposium","first-page":"682","article-title":"Conformationally constrained epitope mimics of the HIV gp41 envelope protein","author":"Bianchi","year":"2003"},{"key":"10.1016\/j.jim.2004.01.016_BIB5","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1021\/bi026261y","article-title":"A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41","volume":"41","author":"Biron","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jim.2004.01.016_BIB6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jim.2004.01.016_BIB7","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1074\/jbc.274.9.5299","article-title":"Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism","volume":"274","author":"Chang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2004.01.016_BIB8","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.201392898","article-title":"Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region","volume":"98","author":"Eckert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2004.01.016_BIB9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of viral membrane fusion and its inhibition","volume":"70","author":"Eckert","year":"2001","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.jim.2004.01.016_BIB10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0092-8674(00)80066-5","article-title":"Inhibiting HIV-1 entry: discovery of d-peptide inhibitors that target the gp41 coiled-coil pocket","volume":"99","author":"Eckert","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jim.2004.01.016_BIB11","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1128\/JVI.76.23.12123-12134.2002","article-title":"Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell\u2013cell fusion","volume":"76","author":"Finnegan","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2004.01.016_BIB12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitides serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2004.01.016_BIB13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/infdis\/156.2.261","article-title":"Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus","volume":"156","author":"Gnann","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2004.01.016_BIB14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","article-title":"Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency","volume":"305","author":"Gottlieb","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2004.01.016_BIB15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/hyb.1987.6.205","article-title":"Quality control of murine monoclonal antibodies using isoelectric focusing affinity immunoblot analysis","volume":"6","author":"Hamilton","year":"1987","journal-title":"Hybridoma"},{"key":"10.1016\/j.jim.2004.01.016_BIB16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/01971528808053217","article-title":"Monoclonal antibody-based immunoenzymetric assays for quantification of human IgG and its four subclasses","volume":"9","author":"Hamilton","year":"1988","journal-title":"J. Immunoass."},{"key":"10.1016\/j.jim.2004.01.016_BIB17","doi-asserted-by":"crossref","first-page":"45811","DOI":"10.1074\/jbc.M205862200","article-title":"Enhancement of alpha-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design","volume":"277","author":"Joyce","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2004.01.016_BIB18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/aid.1998.14.1115","article-title":"Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5","volume":"14","author":"Kunert","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jim.2004.01.016_BIB19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jim.2004.01.016_BIB20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0952-7915(00)00246-6","article-title":"Vaccines for the prevention of HIV-1 disease","volume":"13","author":"Mascola","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jim.2004.01.016_BIB21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2004.01.016_BIB22","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/bi026952u","article-title":"HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb","volume":"42","author":"McGaughey","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jim.2004.01.016_BIB23","first-page":"108","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed Luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2004.01.016_BIB24","first-page":"1","article-title":"Fab-epitope complex from the HIV-1 cross-neutralizing monoclonal antibody 2F5","volume":"vol. WO-00","author":"Pai","year":"2000"},{"key":"10.1016\/j.jim.2004.01.016_BIB25","doi-asserted-by":"crossref","first-page":"10906","DOI":"10.1128\/JVI.75.22.10906-10911.2001","article-title":"Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5","volume":"75","author":"Parker","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2004.01.016_BIB26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/bi991887i","article-title":"The polar region consecutive to the HIV fusion peptide participates in membrane fusion","volume":"39","author":"Peisajovich","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jim.2004.01.016_BIB27","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/JCM.38.6.2043-2050.2000","article-title":"An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study","volume":"38","author":"Plikaytis","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2004.01.016_BIB28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0166-0934(88)90123-1","article-title":"A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity","volume":"20","author":"Robertson","year":"1988","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2004.01.016_BIB29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1057453","article-title":"Protein design of an HIV-1 entry inhibitor","volume":"291","author":"Root","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jim.2004.01.016_BIB30","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.73.3.2469-2480.1999","article-title":"A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity","volume":"73","author":"Salzwedel","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2004.01.016_BIB31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/protein\/11.11.1051","article-title":"An isoleucine zipper peptide forms a native-like triple stranded coiled coil in solution","volume":"11","author":"Suzuki","year":"1998","journal-title":"Protein Eng."},{"key":"10.1016\/j.jim.2004.01.016_BIB32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","article-title":"Multiplexed particle-based flow cytometric assays","volume":"243","author":"Vignali","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2004.01.016_BIB33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/387426a0","article-title":"Atomic structure of the ectodomain from HIV-1 gp41","volume":"387","author":"Weissenhorn","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jim.2004.01.016_BIB34","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.65.9.4832-4838.1991","article-title":"Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies","volume":"65","author":"Xu","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2004.01.016_BIB35","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J. Virol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175904000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175904000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T13:40:32Z","timestamp":1585662032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175904000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022175904000523"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2004.01.016","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}